A single durable medical equipment supplier in Florida submitted roughly $18.4 million in catheter claims to Medicare across two consecutive days in December 2025, a spike large enough that federal investigators caught it before the money reached the supplier. The case surfaced publicly on September 8, 2026, when the Centers for Medicare & Medicaid Services barred eleven durable medical equipment, prosthetics, orthotics and supplies suppliers from future Medicare Advantage and Part D payments over more than $3.4 billion in suspected fraudulent billing in 2025 and 2026. For an older Medicare beneficiary, the exposure is not abstract. Fraudulent DMEPOS billing runs on real people’s Medicare numbers, frequently without their knowledge, and can leave a false claim sitting in a beneficiary’s own record even when no money ever changes hands with the beneficiary directly.
The Two-Day Catheter Billing Spike CMS Caught Before It Paid Out
The Florida-based supplier filed approximately $6.1 million in catheter claims covering 500 beneficiaries on December 15, 2025, then followed with approximately $12.3 million covering 777 beneficiaries the next day, a combined $18.4 million in claims from one supplier inside 48 hours. CMS says its original Medicare payment-suspension authority stopped both waves before the money left the agency, calling the case one of two “particularly egregious” examples among the eleven suppliers now barred from future Medicare Advantage and Part D business. CMS’s release does not name the Florida supplier, consistent with how the agency typically discloses active program-integrity cases before they move toward a public enforcement referral.
A second case in the same September 8 CMS announcement shows the same detection pattern at work: a Texas-based orthotics supplier billed roughly $5.5 million, and investigators interviewed six beneficiaries who said they had never heard of the company and did not need the orthotics billed in their names, while nine other beneficiaries had been billed for dates of service after they had died. CMS also determined that supplier was not operating out of its reported address. Both cases relied on the same tool, a payment-suspension order issued before claims cleared, not a refund pursued after the fact.
Free retirement updates: Miss an enrollment or claim deadline and it may be gone. Our free Retirement Shield newsletter keeps readers ahead of the ones that matter. Get the free newsletter.
What CMS’s Payment-Suspension Authority Actually Stops
A payment suspension differs from denying or later recouping a claim. Once CMS opens a suspension against a supplier, no payment for that supplier’s pending or future claims leaves the Medicare Trust Fund while the action stands, which is why the agency describes the Florida claims as payments prevented from reaching the supplier rather than money recovered afterward. The eleven suppliers named in the September 8 action were also placed on CMS’s Preclusion List, the roster of providers and suppliers barred from Medicare Advantage and Part D payment. Under the rules governing that list, MA plans must deny payment for any item or service furnished by a precluded supplier, and Part D sponsors must reject a pharmacy claim tied to a precluded prescriber. A precluded supplier receives an email and letter in advance, sent to its enrollment address on file, stating the reason for preclusion, the effective date and its appeal rights.
A $3.4 Billion Sweep Built on Data the Suppliers Couldn’t Explain
All eleven suppliers shared a pattern CMS says its systems are built to flag: none had submitted a single Medicare claim before 2025, all had billed for beneficiaries who were already deceased on the date of service, and some supplied equipment that beneficiaries never requested or received. Four of the eleven had already been revoked from Original Medicare and had shifted to billing Medicare Advantage plans instead, a workaround CMS’s Preclusion List was built to close. CMS frames the case as part of a broader push it says delivered its largest results yet: Medicare program integrity savings reached $41.9 billion in fiscal year 2025, up 59% from $26.3 billion the year before, with the agency reporting a program-wide return of $22.3 for every dollar spent on fraud enforcement.
What a Fraudulent DMEPOS Claim Does to a Beneficiary’s Medicare Number
None of the beneficiaries tied to the Florida or Texas claims appear to have paid the suppliers directly. The exposure instead sits in a beneficiary’s own Medicare claims history: a catheter or orthotic device billed to a person’s Medicare number that they never ordered, received or authorized. CMS’s own guidance identifies the Medicare Summary Notice as the official document used to tell a beneficiary what claims were decided under their Medicare number, the record where an unfamiliar DMEPOS charge would first surface for someone enrolled in Original Medicare. An unfamiliar charge is the same signal CMS investigators used against the Texas supplier, where beneficiaries said outright that they did not know the ordering providers and had never needed the equipment billed in their names.
Why HHS-OIG and CMS Call These Cases Particularly Egregious
CMS ran the September 8 action jointly with the U.S. Department of Health and Human Services Office of Inspector General, which the agency credits with helping identify the fraud networks behind the eleven suppliers. CMS Administrator Dr. Mehmet Oz said in the announcement that “brazen scams like these have plagued Medicare for decades, but under President Trump’s leadership and working with the White House Anti-Fraud Task Force, CMS is protecting the Medicare Trust Funds and its beneficiaries by using advanced data analytics to identify fraud networks and stop suspicious payments before the check clears.” CMS says it will keep working with HHS-OIG and its program-integrity partners to catch similar billing spikes before the money leaves the Trust Fund, the same authority that stopped the Florida supplier’s $18.4 million two-day run before a single claim was paid.
This article was produced with the assistance of AI and reviewed by The Financial Wire editorial team.
More Financial Reading
- The ideal retirement withdrawal rate so your savings actually last
- How many CDs can you park at 1 bank? FDIC rules you must know
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
